journal article·2015-09

Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel

Li Zhang, Wenjia Shen, Jiabin Luan, Dongxiao Yang, Gang Wei, Lin Yu, Weiyue Lu, Jiandong Ding

Acta Biomaterialia· Volume 23
Publisher page

Abstract

Delivery of therapeutic agents to posterior segment of the eyes is challenging due to the anatomy and physiology of ocular barriers and thus long-acting implantable formulations are much desired. In this study, a thermogelling system composed of two poly(lactic acid-co-glycolic acid)-poly(ethylene glycol)-poly(lactic acid-co-glycolic acid) (PLGA-PEG-PLGA) triblock copolymers was developed as an injectable matrix for intravitreal drug delivery. The thermogel was prepared by mixing a sol and a precipitate of PLGA-PEG-PLGA triblock copolymers with different block ratios, among which a hydrophobic glucocorticoid, dexamethasone (DEX), was incorporated. The DEX-loaded thermogel was a low-viscous liquid at low temperature and formed a non-flowing gel at body temperature. The in vitro release rate of DEX from the thermogel could be conveniently modulated by varying the mixing ratio of the two copolymers. The long-lasting intraocular residence of the thermogel was demonstrated by intravitreal injection of a fluorescence-labeled thermogel to rabbits. Compared with a DEX suspension, the intravitreal retention time of DEX increased from a dozen hours to over 1week when being loaded in the thermogel. Additionally, intravitreal administration of the thermogel did not impair the morphology of retina and cornea. This study reveals that the injectable PLGA-PEG-PLGA thermogel is a biocompatible carrier for sustained delivery of bioactive agents into the eyes, and provides an alternative approach for treatment of posterior segment diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Retinal Diseases and Treatments · Advanced Drug Delivery Systems · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (64)

Show source-provided references
1. Ocular drug delivery10.1208/s12248-010-9183-3 ↗
2. Transscleral drug delivery for posterior segment disease10.1016/S0169-409X(01)00193-4 ↗
3. Molecular design for enhancement of ocular penetration10.1002/jps.21200 ↗
4. Recent advances in ocular drug delivery10.3109/03639045.2012.736515 ↗
5. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis10.1016/j.addr.2005.08.006 ↗
6. Intravitreal injections: a review of the evidence for best practice10.1111/ceo.12026 ↗
7. New developments in sustained release drug delivery for the treatment of intraocular disease10.1136/bjo.83.11.1225 ↗
8. Short-term complications of intravitreal injections of triamcinolone and bevacizumab10.1038/eye.2008.10 ↗
9. Intraocular sustained drug delivery using implantable polymeric devices10.1016/j.addr.2005.09.005 ↗
10. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging10.1016/j.preteyeres.2013.04.001 ↗
11. Sustained release intraocular drug delivery devices for treatment of uveitis
12. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy10.1167/iovs.13-11777 ↗
13. Hydrogels for protein delivery10.1021/cr200157d ↗
14. Sustained delivery of latanoprost by thermosensitive chitosan–gelatin-based hydrogel for controlling ocular hypertension10.1016/j.actbio.2014.05.031 ↗
15. Enzymatic conjugation of a bioactive peptide into an injectable hyaluronic acid–tyramine hydrogel system to promote the formation of functional vasculature10.1016/j.actbio.2014.02.022 ↗
16. Injectable hydrogels as unique biomedical materials10.1039/b713009k ↗
17. Temperature-responsive compounds as in situ gelling biomedical materials10.1039/c2cs35078e ↗
18. Injectable intratumoral hydrogel as 5-fluorouracil drug depot10.1016/j.biomaterials.2013.01.006 ↗
19. Thermogelling polymer–platinum (IV) conjugates for long-term delivery of cisplatin10.1021/bm501220a ↗
20. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(epsilon-caprolactone) and poly(ethylene glycol)co-polymer10.1016/j.actbio.2012.07.021 ↗
21. Thermogelling PLGA–PEG–PLGA block copolymer as a sustained release matrix of doxorubicin10.1039/c2bm00159d ↗
22. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer10.1016/j.biomaterials.2011.03.007 ↗
23. Influence of LA and GA sequence in the PLGA block on the properties of thermogelling PLGA–PEG–PLGA block copolymers10.1021/bm101572j ↗
24. Effects of molecular weight distribution of amphiphilic block copolymers on their solubility, micellization, and temperature-induced sol–gel transition in water10.1021/ma501110p ↗
25. Thermoreversible hydrogels based on triblock copolymers of poly(ethylene glycol) and carboxyl functionalized poly(e-caprolactone): the effect of carboxyl group substitution on the transition temperature and biocompatibility in plasma10.1016/j.actbio.2014.10.001 ↗
26. Real-time and non-invasive fluorescence tracking of in vivo degradation of the thermosensitive PEGlyated polyester hydrogel10.1039/c4tb00275j ↗
27. Effect of composition on rheological and degradation properties of temperature-responsive gelling systems composed of acyl-capped PCLA–PEG–PCLA10.1021/bm400804w ↗
28. 3D culture of adipose-tissue-derived stem cells mainly leads to chondrogenesis in poly(ethylene glycol)–Poly(l-alanine) diblock copolymer thermogel10.1021/bm400868j ↗
29. Differentiation of tonsil-tissue-derived mesenchymal stem cells controlled by surface-functionalized microspheres in PEG–polypeptide thermogels10.1021/bm500342r ↗
30. Dual ionic interaction system based on polyelectrolyte complex and ionic, injectable, and thermosensitive hydrogel for sustained release of human growth hormone10.1016/j.biomaterials.2012.10.033 ↗
31. Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment10.3109/1061186X.2013.776055 ↗
32. In vitro and in vivo evaluation of a once-weekly formulation of an anti-diabetic peptide drug exenatide in an injectable thermogel10.1002/jps.23735 ↗
33. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel10.1016/j.biomaterials.2013.01.013 ↗
34. Comparative studies of thermogels in preventing post-operative adhesions and corresponding mechanisms10.1039/C4BM00029C ↗
35. Poly(lactic acid-co-glycolic acid)–poly(ethylene glycol)–poly(lactic acid-co-glycolic acid) thermogel as a novel submucosal cushion for endoscopic submucosal dissection10.1016/j.actbio.2013.12.007 ↗
36. Thermosensitive poly-(d,l-lactide-co-glycolide)–block-poly(ethylene glycol)–block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery10.3109/1061186X.2014.931406 ↗
37. Poly(d,l-lactic acid-co-glycolic acid)–b-poly(ethylene glycol)–b-poly(d,l-lactic acid-co-glycolic acid) triblock copolymer and thermoreversible phase transition in water10.1002/jbm.10164 ↗
38. Temperature-induced spontaneous sol-gel transitions of poly(d,l-lactic acid-co-glycolic acid)–b-poly(ethylene glycol)–b-poly(d,l-lactic acid-co-glycolic acid) triblock copolymers and their end-capped derivatives in water10.1002/pola.21876 ↗
39. Mixing a sol and a precipitate of block copolymers with different block ratios leads to an injectable hydrogel10.1021/bm900145g ↗
40. Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water10.1021/bm100549q ↗
41. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,l-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA–PEG–PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis10.1089/jop.2006.132 ↗
42. PLGA–PEG–PLGA hydrogel for ocular drug delivery of dexamethasone acetate10.3109/03639041003680826 ↗
43. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs10.1016/S0168-3659(01)00276-0 ↗
44. Effects of l-lactide and d,l-lactide in poly(lactide-co-glycolide)–poly(ethylene glycol)–poly(lactide-co-glycolide) on the bulk states of triblock copolymers, and their thermogellation and biodegradation in water10.1039/C3RA47494A ↗
45. A subtle end-group effect on macroscopic physical gelation of triblock copolymer aqueous solutions10.1002/anie.200503575 ↗
46. Novel GO-COO–b-CD/CA inclusion: its blood compatibility, antibacterial property and drug delivery10.3109/10717544.2013.846997 ↗
47. In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example10.1016/j.ejps.2014.10.002 ↗
48. Effects of polyvinylpyrrolidone both as a binder and pore-former on the release of sparingly water-soluble topiramate from ethylcellulose coated pellets10.1016/j.ijpharm.2014.02.021 ↗
49. Study of insolubility problems of dexamethasone and digoxin: cyclodextrin complexation
50. Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device10.1167/iovs.02-0956 ↗
51. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine10.1016/j.biomaterials.2011.11.085 ↗
52. Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery10.1371/journal.pone.0100632 ↗
53. Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel10.1021/bm2009558 ↗
54. Controlled release bevacizumab in thermoresponsive hydrogel found to inhibit angiogenesis
55. Ocular biocompatibility of carbodiimide cross-linked hyaluronic acid hydrogels for cell sheet delivery carriers10.1163/156856209X416980 ↗
56. The PEG–PCL–PEG hydrogel as an implanted ophthalmic delivery system after glaucoma filtration surgery; a pilot study
57. Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits10.2147/IJN.S6428 ↗
58. Function and anatomy of the mammalian retina
59. Cell cycle status in human corneal endothelium10.1016/j.exer.2005.06.012 ↗
60. Tissue engineering: a new field and its challenges10.1023/A:1012131329148 ↗
61. Amphiphilic block copolymers for drug delivery10.1002/jps.10397 ↗
62. In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate10.1016/j.actbio.2013.09.024 ↗
63. Evaluation of coupled convective–diffusive transport of drugs administered by intravitreal injection and controlled release implant10.1016/j.jconrel.2005.03.010 ↗
64. Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor10.1023/A:1022207026982 ↗